Simplified Insulin Regimen for the Elderly
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 65 - Any |
| Updated: | 11/22/2018 |
| Start Date: | October 10, 2018 |
| End Date: | June 30, 2020 |
| Contact: | Rajesh Garg, MD |
| Email: | rgarg@miami.edu |
| Phone: | 3056890257 |
Effect of Simplified Insulin Regimen on Glycemic Control and Quality of Life in an Elderly Population With Type 2 Diabetes
Basal-bolus insulin therapy, which includes one injection of long acting insulin and three
injections of short acting insulin is the most commonly used insulin treatment. However, many
older patients find the basal-bolus insulin regimen hard to manage because it involves 4
injections and 4 blood glucose tests each day. It is possible that a simplified treatment
that involves one injection of long acting insulin daily and two blood glucose tests daily
might be equally effective. This simplified regimen, if effective, would be easier to use and
might result in less errors. Therefore, the investigators want to conduct this study to
compare using a single daily injection of basal insulin with the usual basal-bolus insulin
regimen in elderly patients (age >65 years) with type 2 diabetes.
injections of short acting insulin is the most commonly used insulin treatment. However, many
older patients find the basal-bolus insulin regimen hard to manage because it involves 4
injections and 4 blood glucose tests each day. It is possible that a simplified treatment
that involves one injection of long acting insulin daily and two blood glucose tests daily
might be equally effective. This simplified regimen, if effective, would be easier to use and
might result in less errors. Therefore, the investigators want to conduct this study to
compare using a single daily injection of basal insulin with the usual basal-bolus insulin
regimen in elderly patients (age >65 years) with type 2 diabetes.
Inclusion Criteria:
- Age >65 years
- Patient treated with an insulin regimen for at least 3 months
- HbA1c >8% at the time of enrollment
Exclusion Criteria:
- Unable to provide informed consent
- Enrollment in another research study
- History of hypoglycemia unawareness
- Pregnant women
- Prisoners
We found this trial at
1
site
Miami, Florida 33124
(305) 284-2211
Principal Investigator: Rajesh Garg, MD
Phone: 305-689-0257
University of Miami A private research university with more than 15,000 students from around the...
Click here to add this to my saved trials
